You just read:

Interim Phase III Data Show Praxbind® (idarucizumab) Reverses Dabigatran (Pradaxa®) in Emergency Situations

News provided by

Boehringer Ingelheim Pharmaceuticals, Inc.

Apr 02, 2016, 11:30 ET